Abstract: The present invention relates to methods for detecting antibodies, methods for diagnosing lung cancer and kits for lung cancer diagnosis. The methods of the invention are based on a blood or serum sample of a subject. According to a preferred embodiment, the invention uses a combination of different peptides comprising an amino acid stretch of BARD1, short peptides and/or larger fragments thereof. In preferred embodiments, the methods of the invention comprise measuring the amount of autoimmune antibodies in the sample binding to each of the different peptides and applying a statistically determined assessment for making the diagnosis.
Type:
Grant
Filed:
November 5, 2014
Date of Patent:
October 5, 2021
Assignee:
BARD1AG SA
Inventors:
Irmgard Irminger-Finger, Maxim Pilyugin, Pierre-Alain Andre
Abstract: The present invention relates to methods for detecting antibodies, methods for diagnosing lung cancer and kits for lung cancer diagnosis. The methods of the invention are based on a blood or serum sample of a subject. According to a preferred embodiment, the invention uses a combination of different peptides comprising an amino acid stretch of BARD1, short peptides and/or larger fragments thereof. In preferred embodiments, the methods of the invention comprise measuring the amount of autoimmune antibodies in the sample binding to each of the different peptides and applying a statistically determined assessment for making the diagnosis.
Type:
Application
Filed:
November 5, 2014
Publication date:
September 29, 2016
Applicant:
BARD1AG SA
Inventors:
Irmgard IRMINGER-FINGER, Maxime PILYUGIN, Pierre-Alain ANDRE